Search results
Paparo takes helm of INDOPACOM as Aquilino retires from 40-year Navy career
Stars and Stripes· 1 day agoJOINT BASE PEARL HARBOR-HICKAM, Hawaii — Flanked by the nation’s top defense officials, Adm. Samuel...
EU drug watchdog urges COVID-19 vaccine update
Medical Xpress· 5 days agoThe most widely circulating COVID variant worldwide is now JN.1, having overtaken the XBB family that is the target of the most recent vaccines, the...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 4 days agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook - GSK (NYSE:GSK)
Benzinga· 4 days agoVaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand...
GSK raises profit outlook on strong vaccine, HIV drug sales
Reuters via Yahoo Finance· 4 days ago(Reuters) -GSK raised its full-year profit forecast on Wednesday on strong demand for its common...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 20 hours agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
GSK raises profit outlook on strong vaccine, HIV drug sales By Reuters
Investing.com· 4 days agoCEO Emma Walmsley's strategy has focussed on vaccines, cancer and infectious diseases and a shift in...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 20 hours agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
GSK Lifts Guidance After Turnover Beats Expectations
The Wall Street Journal· 4 days agoGSK expects sales growth in the first half of the year to be higher than in the second half based on demand for its respiratory virus and shingles ...
Biotech’s bind over China bill
Politico· 2 days agoMODERNA BULLISH ON RSV SHOT — Moderna executives signaled confidence Thursday that the drugmaker’s RSV vaccine can compete with shots already on the market if the FDA approves ...